Platelet-Rich Plasma (PRP) therapy in China typically costs from $280 to $700 per session. The final price depends on the hospital tier, city, and application area like orthopedics or aesthetics. Patients save approximately 46% compared to the United States, where average costs reach $900. Basic treatments usually include blood collection, centrifugation, and the injection procedure.
Bookimed Expert Insight: Choosing JCI-accredited facilities ensures international standards in cities like Haikou or Hangzhou. Sir Run Run Shaw Hospital (SRRSH) stands out as the first Mayo Clinic Care Network member. Hainan Chengmei Hospital offers high-end service blending medical and hotel standards with JCI accreditation. For complex orthopedic PRP, Shanghai Tongji Hospital features experts like Professor Chen Biao for evidence-based care. These top-tier centers manage massive patient volumes, ensuring high procedural proficiency for international patients.
| China | Turkey | The USA | |
| Platelet-Rich Plasma (PRP) Therapy | ≈ $280 | from $290 | ≈ $600 |
No hidden fees – just official clinic prices. Pay at the clinic for Platelet-Rich Plasma (PRP) Therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Platelet-Rich Plasma (PRP) Therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Platelet-Rich Plasma (PRP) Therapy journey.
Dr. Wasin Naknam is a reproductive medicine specialist at DHC IVF Shenzhen. He holds Thai board certifications in infertility and assisted reproductive technology. Dr. Naknam earned a master’s degree in biotechnology of human reproduction from the University of Valencia. He presented original research at the ESHRE 2020 annual meeting.
Professor Cheng Biao is Chief Physician, Professor, and Doctoral Supervisor of Orthopedics at Shanghai Tongji Hospital. He specializes in complex joint disease and sports trauma. His focus areas are arthroplasty and arthroscopy.
Scope includes knee and hip arthroplasty, meniscectomy, and rotator cuff, ACL, and Bankart repair. He also treats DDH, patellar and shoulder instability, axial spondyloarthritis, Kashin–Beck disease, and major‑joint osteoarthritis.
He is Deputy Head of the Arthroscopy Group, Shanghai Medical Doctor Association, and a founding member of the Chinese Shoulder & Elbow Collaborative. His awards include the Shanghai Medical Science & Technology Award (Third Prize) and the Shanghai Science & Technology Progress Award. He also serves as an international medical expert at the Shanghai World International Medical Center.